Age (years) |
|
|
<50 |
20 |
38.5 |
≥ 50 |
32 |
61.5 |
Gender |
|
|
Male |
20 |
38.5 |
Female |
32 |
61.5 |
Race |
|
|
American Indian/Alaska Native |
1 |
1.9 |
Asian |
1 |
1.9 |
Black or African American |
4 |
7.7 |
Native Hawaiian or Other Pacific Islander |
0 |
0.0 |
White |
44 |
84.6 |
Unknown or not reported |
2 |
3.8 |
Ethnicity |
|
|
Hispanic or Latino |
4 |
7.7 |
Not Hispanic or Latino |
45 |
86.5 |
Unknown (Individuals not reporting ethnicity) |
3 |
5.8 |
Pre-treatment Zubrod performance status |
|
|
0 |
39 |
75.0 |
1 |
13 |
25.0 |
Pre-treatment Neurologic Function |
|
|
No symptoms |
27 |
51.9 |
Minor symptoms |
21 |
40.4 |
Moderate symptoms |
4 |
7.7 |
Status of Tumor |
|
|
Initial diagnosis |
36 |
69.2 |
Recurrent |
16 |
30.8 |
Extent of Resection (Simpson Grade) |
|
|
Initial - Grade I |
7 |
13.5 |
Initial - Grade II |
17 |
32.7 |
Initial - Grade III |
8 |
15.4 |
Initial - Grade IV |
2 |
3.8 |
Initial - unknown |
2 |
3.8 |
Recurrent - Grade I |
0 |
0.0 |
Recurrent - Grade II |
0 |
0.0 |
Recurrent - Grade III |
0 |
0.0 |
Recurrent - Grade IV |
3 |
5.8 |
Recurrent - by imaging only |
13 |
25.0 |
Histology |
|
|
Initial - WHO grade I |
2 |
3.8 |
Initial - WHO grade II |
32 |
61.5 |
Initial - WHO grade III |
1 |
1.9 |
Initial - unknown |
1 |
1.9 |
Recurrent - WHO grade I |
2 |
3.8 |
Recurrent - WHO grade II |
1 |
1.9 |
Recurrent - WHO grade III |
0 |
0.0 |
Recurrent - by imaging only |
13 |
25.0 |
Lateralization of Tumor |
|
|
Right |
20 |
38.5 |
Left |
25 |
48.1 |
Bilateral |
7 |
13.5 |
Unknown |
0 |
0.0 |
|
Total |
52 |
100.0 |